High efficacy of eight weeks of ledipasvir/sofosbuvir (LDV/SOF) in African Americans with hepatitis C virus genotype 1 infection in a real-world clinic setting.
Citation: 2018/04/30/Department: Medicine/Infectious DiseasesForm of publication: Poster PresentationYear: 2018Conference information: MedStar Health Research Institute: MedStar Health Research Symposium, North Bethesda, MD, Fiscal year: FY2018Local accession number: B2018206Date added to catalog: 2019-07-31Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |